Home > Animal Health & Nutrition > Veterinary Pharmaceuticals > Brucellosis Vaccine Market

Brucellosis Vaccine Market Share

Report ID: GMI9544
Published Date: May 2024
Report Format: PDF

Download Free Sample

Brucellosis Vaccine Market Share

The brucellosis vaccine industry is highly competitive characterized by the presence of several key players, including pharmaceutical companies, biotechnology firms, and veterinary vaccine manufacturers. These companies engage in research, development, production, and distribution of brucellosis vaccines, striving to gain market share and maintain competitiveness through innovation, strategic partnerships, and regulatory compliance.

Brucellosis Vaccine Market Companies

Prominent players operating in the brucellosis vaccine industry include:

Ceva
Colorado Serum Company
Creative Biolabs
CZ Vaccines
Fivet Animal Health
Hester Biosciences Limited
Indian Immunologicals Ltd.
Jordan Bio-industries Center
Laboratories Tornel
Merck & Co., Inc.
VETAL Animal Health Products Inc.
Veterinary Technologies Corporation

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global brucellosis vaccine market size accounted for USD 242.4 million in 2023 and is projected to grow at 4.9% CAGR during 2024-2032, driven by increasing prevalence of brucellosis in livestock.

The RB51 vaccine type segment in the brucellosis vaccine recorded 43.7% share in 2023 and will expand rapidly through 2032, as it has demonstrated high efficacy in protecting against brucella abortus infection in cattle.

North America brucellosis vaccine market size was valued at USD 99.4 million in 2023 and is predicted to reach USD 150.7 million by 2032, owing to significant livestock population, particularly cattle, which is highly susceptible to brucella abortus infection.

Ceva, Colorado Serum Company, Creative Biolabs, CZ Vaccines, Fivet Animal Health, Hester Biosciences Limited, Indian Immunologicals Ltd., Jordan Bio-industries Center and Laboratories Tornel among others.